Sign in
4

Changes in Ownership

HERON THERAPEUTICS, INC. /DE/ Filed Acc 0001209191-21-046791

EVP, Chief Operating Officer acquired 1,530 shares (other)

  • EVP, Chief Operating Officer gave up 433 shares (to pay taxes)
  • EVP, Chief Operating Officer acquired 1,250 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Szekeres David Leslie EVP, Chief Operating Officer 2021-04-30 Other acquisition +1,530 $13.90 $21,263 2,347 D
Szekeres David Leslie EVP, Chief Operating Officer 2021-07-13 Option exercise +1,250 3,597 D
Szekeres David Leslie EVP, Chief Operating Officer 2021-07-13 Shares withheld for taxes −433 $13.48 $5,837 3,164 D
Derivatives
Szekeres David Leslie EVP, Chief Operating Officer 2021-07-13 Option exercise · Restricted Stock Units −1,250 16,250 D
Loading xslF345X03/doc4.xml…